4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-25-000197
Chief Executive Officer gave up 17,787 shares (to pay taxes)
- Chief Executive Officer acquired 64,867 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NEIL GARRY ARTHUR Chief Executive Officer | 2025-03-28 | Option exercise | +64,867 | 64,927 | D: show line 1 in the form | ||
| NEIL GARRY ARTHUR Chief Executive Officer | 2025-03-28 | Shares withheld for taxes | −17,787 | $8.46 | $150,478 | 47,140 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| NEIL GARRY ARTHUR Chief Executive Officer | 2025-03-28 | Option exercise · Restricted Stock Units | +64,867 | 129,733 | D: show line 3 in the form |
Loading xslF345X05/primary_doc.xml…